MindMed | Investor Presentation Deck | 33 slides

MindMed · 2021-04
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

33
every slide · same image gating as the playbook
01
Slide 1
Includes stock ticker symbols for NEO, OTCQB, and DE exchanges.front_matter
04
The slide uses a four-column layout to synthesize market size, strategy, institutional momentum, and regulatory compliance.establish_context
05
The slide uses a 'problem statement' framing to justify the market size for mental health solutions.size_opportunity
Open slide detailBeat · Agitate
06
Uses a combination of metrics to show treatment gaps and a comparative table to argue for safety.frame_problem
Open slide detailBeat · Problem
07
The slide uses a comparison framework to distinguish between two distinct product delivery models.present_solution
Open slide detailBeat · Solution
08
The slide uses a two-column layout: left side details institutional partners (Basel, Maastricht) and right side lists key individual researchers.cite_precedent
09
The slide uses a linear process flow to map out the company's core business activities.plan_implementation
10
The slide uses a Gantt-style chart to show the progress of different drug projects.plan_implementation
11
transition
12
Includes headshots of Dr. Peter Gasser and Dr. Matthias Liechti. Mentions specific cost and time savings based on industry averages.plan_implementation
13
Includes a timeline visualization and a map indicating trial locations.plan_implementation
14
Uses a line chart to represent dopamine levels over time across different states (Repeated Opioid Use, Addiction, Current Treatment, 18-MC).present_solution
15
The slide uses a Gantt-style timeline and a structured list for trial design.plan_implementation
16
transition
17
The slide emphasizes the depth of clinical data acquired through the Liechti Lab collaboration.show_traction
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
18
The slide uses a hand holding a pill as a visual metaphor for the pharmaceutical focus.present_solution
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
19
The slide highlights a specific IP asset (LSD Neutralizer) as a competitive advantage for safety and control.present_solution
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
20
The slide outlines the strategic intent of the MindShift partnership to create a new pipeline of drug candidates.present_solution
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
21
The slide highlights a specific research initiative led by Dr. Kim Kuypers.show_traction
Open slide detailBeat · Evidence & ProofLoop · Aha Moment
22
transition
23
Highlights a strategic partnership with a major medical institution.other
24
The slide uses a three-pillar framework (Measure, Analyze, Commercialize) to explain the platform's value proposition.present_solution
25
The slide includes a list of clinical areas, a section on COVID-19 impact, and a logo grid of partners.show_traction
26
plan_implementation
Open slide detailLoop · Why Now
27
Includes ticker symbols and specific dates for market cap and share ownership data.analyze_data
28
The slide uses a grid layout to display six board members, each with a headshot, title, biography, and associated company logos.other
30
The slide uses a grid layout to display 9 advisors with headshots, names, titles, and logos.other
31
Uses a grid layout to display logos and associated pull-quotes from major publications.show_traction
33
front_matter